This study aimed to validate the IdyllaTM platform for the detection of EGFR/KRAS mutations in cytological NSCLC samples prepared as cytoblocks using AGAR and paraffin embedding. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.